Renin-angiotensin system inhibitors in the COVID-19 pandemic: consequences of antihypertensive drugs
- PMID: 32498078
- PMCID: PMC7314098
- DOI: 10.1093/eurheartj/ehaa487
Renin-angiotensin system inhibitors in the COVID-19 pandemic: consequences of antihypertensive drugs
Figures
Comment on
-
Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study.Eur Heart J. 2020 Jun 7;41(22):2058-2066. doi: 10.1093/eurheartj/ehaa433. Eur Heart J. 2020. PMID: 32498076 Free PMC article.
References
-
- Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS, China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708–1720. - PMC - PubMed
-
- Gao C, Cai Y, Zhang K, Zhou L, Zhang Y, Zhang X, Li Q, Li W, Yang S, Zhao X, Zhao Y, Wang H, Liu Y, Yin Z, Zhang R, Wnag R, Yang M, Hui C, Wijns W, McEvoy W, Soliman O, Onuma Y, Serruys PW, Tao L, Li F.. Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study. Eur Heart J 2020;41:2058–2066. - PMC - PubMed
-
- Ruilope LM, Bakris GL.. Renal function and target organ damage in hypertension. Eur Heart J 2011;32:1599–604. - PubMed
-
- Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, Yu T, Wang Y, Pan S, Zou X, Yuan S, Shang Y.. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020;8:475–481. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
